Company’s antibody profiling technology could
Author: Michael
Illumina, based in San Diego, announced it will a
New review from global geroscience experts maps
Combining next generation sequencing with advanc
New review explores metformin’s expanding pote
Companies harness AI to identify drugs that targ
“Carmat, the France-based developer of the Aeso
Small-scale study of once-daily oral drug demons
RenewalBio is targeting longevity with a unique
New white paper from second Roundtable explores